The U.S. Food and Drug Administration (FDA) on Friday cleared Dexcom Inc.‘s DXCM Stelo Glucose Biosensor System for ...
The FDA’s indication expansion for Dexcom’s Stelo makes it the first over the counter CGM available for children, including ...
CGMs can help people avoid serious diabetes complications, save money through better management and adjust behavior based on feedback.
Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...